EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Flavonol Technology: From the Compounds’ Chemistry to Clinical Research

Tomasz Przybylski iD, Joanna Czerniel iD, Jakub Dobrosielski, Maciej Stawny iD

Molecules · 2025

DOI: 10.3390/molecules30153113 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Tomasz Przybylski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland. Hauptthemen laut MEDLINE: Flavonols. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, National Science Centre, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flavonols, representing a subclass of flavonoids, are an important group of polyphenols. Their activity is associated with a number of beneficial properties, including hepatoprotective, senolytic, neuroprotective, and anticancer properties. They are found abundantly in many fruits, vegetables, and plant products, but flavonols’ chemistry and structural properties result in their low bioavailability in vivo. In recent years, more and more studies have emerged that aim to increase the therapeutic potential of compounds belonging to this group, including by developing innovative nanoformulations. The present work focuses on the various steps, such as chemical analysis of the compounds, preformulation studies using drug delivery systems, preclinical studies, and finally clinical trials. Each of these elements is important not only for the innovation and efficacy of the therapy but most importantly for the patient’s health. There are also a limited number of studies assessing the population concentration of flavonols in the blood; therefore, this review presents an up-to-date survey of the most recent developments, using the most important compounds from the flavonol group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonolsHumansAnimalsDrug Delivery SystemsBiological Availability

Stichwörter der Autor:innen

drug delivery systemsfisetinflavonolsgut microbiotananotechnologyparenteral nutritionquercetin

Substanzen

Flavonols

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
  • Doctoral School, Poznan University of Medical Sciences, Bukowska 70, 60-812 Poznan, Poland.

ORCID-Profile: Tomasz Przybylski, Joanna Czerniel, Maciej Stawny

Förderung

  • National Science Center
  • National Science Centre, Poland

Zitieren

APA

Przybylski, T., Czerniel, J., Dobrosielski, J., & Stawny, M. (2025). Flavonol Technology: From the Compounds’ Chemistry to Clinical Research. Molecules. https://doi.org/10.3390/molecules30153113

Vancouver

Przybylski T, Czerniel J, Dobrosielski J, Stawny M. Flavonol Technology: From the Compounds’ Chemistry to Clinical Research. Molecules. 2025. doi:10.3390/molecules30153113

BibTeX
@article{Przybylski2025,
  author = {Przybylski, Tomasz and Czerniel, Joanna and Dobrosielski, Jakub and Stawny, Maciej},
  title = {Flavonol Technology: From the Compounds’ Chemistry to Clinical Research},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30153113}
}
Kostenlos starten →